miRNAs can be generally associated with human pathologies as exemplified for miR-144

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Keller, Andreas ^a   Leidinger, Petra ^b   Vogel, Britta ^c   Backes, Christina ^a   ElSharawy, Abdou ^d   Galata, Valentina ^a   Mueller, Sabine C ^a   Marquart, Sabine ^c   Schrauder, Michael G ^e   Strick, Reiner ^e   Bauer, Andrea ^f   Wischhusen, Jörg ^g   Beier, Markus ^h   Kohlhaas, Jochen ^h   Katus, Hugo A ^c,i   Hoheisel, Jörg ^f   Franke, Andre ^d   Meder, Benjamin ^c,i   Meese, Eckart ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^h The Comprehensive Biomarker Center GmbH   (Germany)

ⁱ DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Bioinformatics; Biomarker; Microarray; miRNA

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 20B; MIRNA 144; UNCLASSIFIED DRUG; MIRN144 MICRORNA, HUMAN; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SCREENING; GENOME; HUMAN; ICD-10; MAJOR CLINICAL STUDY; NEOPLASM; PATHOLOGY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MIDDLE AGED; PROGNOSIS; VALIDATION STUDY;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASMS; PHENOTYPE; PROGNOSIS;

EID: 84964313396     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0224-0     Document Type: Article

References (46)

1. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Kozomara A, Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-157.
3. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-144.
4. Pogue AI, Cui JG, Li YY, Zhao Y, Culicchia F, Lukiw WJ: Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 2010, 476:18-22.
5. Cheng AM, Byrom MW, Shelton J, Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.
6. Yoshizawa M, Taguchi YH, Yasuda J: Inference of gene regulation via miRNAs during ES cell differentiation using miRaGE method. Int J Mol Sci 2011, 12:9265-9276.
7. Laczny C, Leidinger P, Haas J, Ludwig N, Backes C, Gerasch A, Kaufmann M, Vogel B, Katus HA, Meder B, Stähler C, Meese E, Lenhof HP, Keller A: miRTrail -a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases. BMC Bioinformatics 2012, 13:36.
8. van Kouwenhove M, Kedde M, Agami R: MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 2011, 11:644-656.
9. Backes C, Meese E, Lenhof HP, Keller A: A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res 2010, 38:4476-4486.
10. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
11. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
12. Chan JA, Krichevsky AM, Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65:6029-6033.
13. Vogel B, Keller A, Frese KS, Leidinger P, Sedaghat-Hamedani F, Kayvanpour E, Kloos W, Backe C, Thanaraj A, Brefort T, Beier M, Hardt S, Meese E, Katus HA, Meder B: Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure. Eur Heart Jss 2013, 34:2812-2822.
14. Fu Y, Yi Z, Wu X, Li J, Xu F: Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 2011, 49:4246-4251.
15. Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W: Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011, 104:847-851.
16. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E: Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011, 8:506-516.
17. Gotte M: MicroRNAs in breast cancer pathogenesis. Minerva Ginecol 2010, 62:559-571.
18. Yin Y, Li M, Li H, Jiang Y, Cao LY, Zhang HF, Xu XC: Expressions of 6 microRNAs in prostate cancer. Zhonghua Nan Ke Xue 2010, 16:599-605.
19. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59.
20. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, Leidinger P, Meese E, Katus HA, Rottbauer W: MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 2011, 106:13-23.
21. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E: miRNAs in lung cancer -studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9:353.
22. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E: Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009, 4:e7440.
23. Keller A, Leidinger P, Steinmeyer F, Stahler C, Franke A, Hemmrich-Stanisak G, Kappel A, Wright I, Dorr J, Paul F, Diem R, Tocariu-Krick B, Meder B, Backes C, Meese E, Ruprecht K: Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler 2014, 20:295-303.
24. Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, Lenhof HP, Meese E: High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 2010, 10:262.
25. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, Krockenberger M, Engel JB, Honig A, Scheffler M, Dietl J, Wischhusen J: Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 2010, 103:693-700.
26. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, Lenhof HP, Meese E: Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011, 74:41-47.
27. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A: A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 2011, 118:449-457.
28. Leidinger P, Backes C, Deutscher S, Schmitt K, Muller SC, Frese K, Haas J, Ruprecht K, Paul F, Stahler C, Lang CJ, Meder B, Bartfai T, Meese E, Keller A: A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 2013, 14:R78.
29. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Müller-Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, et al: Toward the blood-borne miRNome of human diseases. Nat Meth 2011, 8:841-843.
30. The R Project for Statistical Computing. [http://www.r-project.org/]
31. miRTarBase: the experimentally validated microRNA-target interactions database. http://mirtarbase.mbc.nctu.edu.tw/.
32. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, Jian TY, Lin FM, Chang TH, Weng SL, Liao KW, Liao IE, Liu CC, Huang HD: miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 2014, 42:D78-85.
33. GeneTrail -A gene set property analysis tool. http://genetrail.bioinf.uni-sb.de.
34. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, Elnakady YA, Muller R, Meese E, Lenhof HP: GeneTrail -advanced gene set enrichment analysis. Nucleic Acids Res 2007, 35:W186-192.
35. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
36. Mendell JT: miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
37. The human microRNA disease database. http://www.cuilab.cn/hmdd.
38. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q: An analysis of human microRNA and disease associations. PLoS One 2008, 3:e3420.
39. Lu TX, Sherrill JD, Wen T, Plassard AJ, Besse JA, Abonia JP, Franciosi JP, Putnam PE, Eby M, Martin LJ, Aronow BJ, Rothenberg ME: MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol 2011, 129:1064-1075.
40. Liu Y, Wang X, Jiang J, Cao Z, Yang B, Cheng X: Modulation of T cell cytokine production by miR-144*with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 2011, 48:1084-1090.
41. Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J TranslMed 2012, 10:55.
42. Kalimutho M, Del Vecchio BG, Di Cecilia S, Sileri P, Cretella M, Pallone F, Federici G, Bernardini S: Differential expression of miR-144*as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol 2011, 46:1391-1402.
43. Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB: Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS One 2011, 6:e23935.
44. Bauer AS, Keller A, Costello E, Greenhalf W, Bier M, Borries A, Beier M, Neoptolemos J, Buchler M, Werner J, Giese N, Hoheisel JD: Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 2012, 7:e34151.
45. Leidinger P, Backes C, Meder B, Meese E, Keller A: The human miRNA repertoire of different blood compounds. BMC Genomics 2014, 15:474.
46. Meder B, Backes C, Haas J, Leidinger P, Stahler C, Grossmann T, Vogel B, Frese K, Giannitsis E, Katus HA, Meese E, Keller A: Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin Chem 2014, 60:1200-1208.